SOURCES:
Jonathan Whiteson, MD, co-director, NYU Langone Health Post COVID Care Program.
American Academy of Physical Medicine and Rehabilitation: “Long COVID/PASC.”
Lancet: “Risk of Long COVID Associated With Delta Versus Omicron Variants of SARS-CoV-2.”
Nature Communications: “Post-Covid Medical Complaints Following Infection With SARS-CoV-2 Omicron vs Delta Variants.”
Karin Magnusson, PhD, researcher, Norwegian Institute of Public Health, Oslo, and Lund University, Sweden.
FDA: “COVID-19 Bivalent Vaccine Boosters.”
medRxiv: “Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study From the RECOVER Program.”
Antimicrobial Stewardship & Healthcare Epidemiology: “The Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccine in the Prevention of Post-COVID Conditions: A Systematic Literature Review and Meta-Analysis.”
Alexandre Marra, MD, researcher, Hospital Israelita Albert Einstein, São Paulo, Brazil; researcher, University of Iowa Carver College of Medicine, Iowa City.
FDA: “Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose.”
FDA: “Coronavirus (COVID-19) Update: FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age.”
Daniel Brannock, research data scientist, RTI International.
CDC: “Respiratory Infections.”
European Center for Disease Prevention and Control: “Prevalence of Post COVID-19 Condition Symptoms: A Systematic Review and Meta-Analysis of Cohort Study Data, Stratified by Recruitment Setting.”
Journal of Internal Medicine: “Post COVID-19 Condition Diagnosis: A Population-Based Cohort Study of Occurrence, Associated Factors, and Healthcare Use by Severity of Acute Infection.”
Akiko Iwasaki, PhD, director, Center for Infection and Immunity, Yale University.
American Academy of Physical Medicine and Rehabilitation: “PASC Dashboard.”
National Center for Health Statistics: “Identification of Deaths With Post-acute Sequelae of COVID-19 From Death Certificate Literal Text: United States, January 1, 2020–June 30, 2022.”
